Works by NEGRIER, C.

Results: 70

Description of 10 new mutations in platelet glycoprotein IIb (αIIb) and glycoprotein IIIa (β3) genes.

Published in:

Platelets, 2001, v. 12, n. 8, p. 486, doi. 10.1080/095371001317126383

By:

Vinciguerra, C.;
Bordet, J. C.;
Beaune, G.;
Grenier, C.;
Dechavanne, M.;
Négrier, C.

Publication type:

Article

Identification of new and known polymorphisms in glycoprotein IIb and IIIa genes by denaturing gradient gel electrophoresis.

Published in:

Platelets, 1998, v. 9, n. 6, p. 374, doi. 10.1080/09537109876447

By:

Negrier, C.

Publication type:

Article

Hepatitis A in French Hemophiliacs.

Published in:

Vox Sanguinis, 1994, v. 67, p. 9, doi. 10.1111/j.1423-0410.1994.tb00966.x

By:

Goudemand, J.;
Parquet, A.;
D'Oiron, R.;
Stieltjes, N.;
Guérois, C.;
Fonlupt, J.;
Alcalay, M.;
Négrier, C.;
Cazenave, J.P.;
Briquel, M.E.;
Fressinaud, E.

Publication type:

Article

A nonsense mutation in the GPIIb heavy chain (Ser 870 → stop) impairs platelet GPIIb-IIIa expression.

Published in:

British Journal of Haematology, 1996, v. 95, n. 2, p. 399, doi. 10.1046/j.1365-2141.1996.d01-1903.x

By:

VINCIGUERRA, C.;
KHELIF, A.;
ALEMANY, M.;
MORLE, F.;
GRENIER, C.;
UZAN, G.;
GULINO, D.;
DECHAVANNE, M.;
NEGRIER, C.

Publication type:

Article

Efficacy and safety of long-acting recombinant fusion protein linking factor IX with albumin in haemophilia B patients undergoing surgery.

Published in:

Haemophilia, 2016, v. 22, n. 4, p. e259, doi. 10.1111/hae.12972

By:

Négrier, C.;
Abdul Karim, F.;
Lepatan, L. M.;
Lienhart, A.;
López‐Fernández, M. F.;
Mahlangu, J.;
Pabinger, I.;
Li, Y.;
Wolko, D.;
Voigt, C.;
Jacobs, I.;
Santagostino, E.

Publication type:

Article

Recombinant long-acting glyco PEGylated factor IX (nonacog beta pegol) in haemophilia B: assessment of target joints in multinational phase 3 clinical trials.

Published in:

Haemophilia, 2016, v. 22, n. 4, p. 507, doi. 10.1111/hae.12902

By:

Negrier, C.;
Young, G.;
Abdul Karim, F.;
Collins, P. W.;
Hanabusa, H.;
Colberg, T.;
Goldman, B.;
Walsh, C. E.

Publication type:

Article

Characterization of five associations of F8 missense mutations containing FVIII B domain mutations.

Published in:

Haemophilia, 2016, v. 22, n. 4, p. 583, doi. 10.1111/hae.12906

By:

Jourdy, Y.;
Nougier, C.;
Roualdes, O.;
Fretigny, M.;
Durand, B.;
Negrier, C.;
Vinciguerra, C.

Publication type:

Article

Dosing regimens, FVIII levels and estimated haemostatic protection with special focus on rFVIIIFc.

Published in:

Haemophilia, 2016, v. 22, n. 3, p. 389, doi. 10.1111/hae.12887

By:

Berntorp, E.;
Negrier, C.;
Gozzi, P.;
Blaas, P‐M.;
Lethagen, S.

Publication type:

Article

Achievements, challenges and unmet needs for haemophilia patients with inhibitors.

Published in:

Haemophilia, 2016, v. 22, p. 1, doi. 10.1111/hae.12860

By:

Dargaud, Y.;
Pavlova, A.;
Lacroix-Desmazes, S.;
Fischer, K.;
Soucie, M.;
Claeyssens, S.;
Scott, D.w.;
d'Oiron, R.;
Lavigne-Lissalde, G.;
Kenet, G.;
Escuriola Ettingshausen, C.;
Borel-Derlon, A.;
Lambert, T.;
Pasta, G.;
Négrier, C.

Publication type:

Article

In vivo efficacy of human recombinant factor IX produced by the human hepatoma cell line HuH-7.

Published in:

Haemophilia, 2015, v. 21, n. 4, p. e317, doi. 10.1111/hae.12688

By:

Enjolras, N.;
Perot, E.;
Le Quellec, S.;
Indalecio, A.;
Girard, J.;
Negrier, C.;
Dargaud, Y.

Publication type:

Article

Usefulness of an in vitro cellular expression model for haemophilia A carrier diagnosis: illustration with five novel mutations in the F8 gene in women with isolated factor VIII:C deficiency.

Published in:

Haemophilia, 2015, v. 21, n. 3, p. e202, doi. 10.1111/hae.12651

By:

Roualdes, O.;
Nougier, C.;
Fretigny, M.;
Talagrand, E.;
Durand, B.;
Negrier, C.;
Vinciguerra, C.

Publication type:

Article

FEIBA in the treatment of acquired haemophilia A: Results from the prospective multicentre French ' FEIBA dans l'hémophilie A acquise' ( FEIBHAC) registry.

Published in:

Haemophilia, 2015, v. 21, n. 3, p. 330, doi. 10.1111/hae.12574

By:

Borg, J.‐Y.;
Négrier, C.;
Durieu, I.;
Dolimier, E.;
Masquelier, A.‐M.;
Lévesque, H.

Publication type:

Article

Spotlight on the human factor: building a foundation for the future of haemophilia A management.

Published in:

Haemophilia, 2015, v. 21, p. 1, doi. 10.1111/hae.12582

By:

Kessler, C.;
Oldenburg, J.;
Ettingshausen, C. Escuriola;
Tiede, A.;
Khair, K.;
Négrier, C.;
Klamroth, R.

Publication type:

Article

Diagnosis and management challenges in patients with mild haemophilia A and discrepant FVIII measurements.

Published in:

Haemophilia, 2014, v. 20, n. 4, p. 550, doi. 10.1111/hae.12381

By:

Trossaert, M.;
Lienhart, A.;
Nougier, C.;
Fretigny, M.;
Sigaud, M.;
Meunier, S.;
Fouassier, M.;
Ternisien, C.;
Negrier, C.;
Dargaud, Y.

Publication type:

Article

Characterization of four novel molecular changes in the promoter region of the factor VIII gene.

Published in:

Haemophilia, 2014, v. 20, n. 2, p. e149, doi. 10.1111/hae.12346

By:

Nougier, C.;
Roualdes, O.;
Fretigny, M.;
d'Oiron, R.;
Costa, C.;
Negrier, C.;
Vinciguerra, C.

Publication type:

Article

The first recombinant FVIII produced in human cells - an update on its clinical development programme.

Published in:

Haemophilia, 2014, v. 20, p. 1, doi. 10.1111/hae.12322

By:

Valentino, L. A.;
Negrier, C.;
Kohla, G.;
Tiede, A.;
Liesner, R.;
Hart, D.;
Knaub, S.

Publication type:

Article

Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro- FEIBA study.

Published in:

Haemophilia, 2013, v. 19, n. 5, p. 736, doi. 10.1111/hae.12178

By:

Gringeri, A.;
Leissinger, C.;
Cortesi, P. A.;
Jo, H.;
Fusco, F.;
Riva, S.;
Antmen, B.;
Berntorp, E.;
Biasoli, C.;
Carpenter, S.;
Kavakli, K.;
Morfini, M.;
Négrier, C.;
Rocino, A.;
Schramm, W.;
Windyga, J.;
Zülfikar, B.;
Mantovani, L. G.

Publication type:

Article

The benefits of exercise for patients with haemophilia and recommendations for safe and effective physical activity.

Published in:

Haemophilia, 2013, v. 19, n. 4, p. 487, doi. 10.1111/hae.12118

By:

Negrier, C.;
Seuser, A.;
Forsyth, A.;
Lobet, S.;
Llinas, A.;
Rosas, M.;
Heijnen, L.

Publication type:

Article

SURgical interventions with FEIBA ( SURF): international registry of surgery in haemophilia patients with inhibitory antibodies.

Published in:

Haemophilia, 2013, v. 19, n. 3, p. e143, doi. 10.1111/hae.12080

By:

Négrier, C.;
Lienhart, A.;
Numerof, R.;
Stephens, D.;
Wong, W. Y.;
Baghaei, F.;
Yee, T. T.

Publication type:

Article

Use of Haemate® P as immune tolerance induction in patients with severe haemophilia A who failed previous induction attempts: a multicentre observational study.

Published in:

Haemophilia, 2013, v. 19, n. 2, p. 281, doi. 10.1111/hae.12018

By:

Rothschild, C.;
D'oiron, R.;
Borel‐derlon, A.;
Gruel, Y.;
Navarro, R.;
Negrier, C.

Publication type:

Article

Consensus recommendations for the use of FEIBA® in haemophilia A patients with inhibitors undergoing elective orthopaedic and non-orthopaedic surgery.

Published in:

Haemophilia, 2013, v. 19, n. 2, p. 294, doi. 10.1111/hae.12028

By:

Rangarajan, S.;
Austin, S.;
Goddard, N. J.;
Négrier, C.;
Rodriguez‐Merchan, E. C.;
Stephensen, D.;
Yee, T. T.

Publication type:

Article

The potential role of synovial thrombomodulin in the pathophysiology of joint bleeds in haemophilia.

Published in:

Haemophilia, 2012, v. 18, n. 5, p. 818, doi. 10.1111/j.1365-2516.2012.02809.x

By:

DARGAUD, Y.;
SIMPSON, H.;
CHEVALIER, Y.;
SCOAZEC, J. Y.;
HOT, A.;
GUYEN, O.;
BAGLIN, T.;
NÉGRIER, C.

Publication type:

Article

Global haemostasis and point of care testing.

Published in:

Haemophilia, 2012, v. 18, p. 81, doi. 10.1111/j.1365-2516.2012.02855.x

By:

DARGAUD, Y.;
SORENSEN, B.;
SHIMA, M.;
HAYWARD, C.;
SRIVASTAVA, A.;
NEGRIER, C.

Publication type:

Article

Evaluation of the overall haemostatic effect of recombinant factor VIIa by measuring thrombin generation and stability of fibrin clots.

Published in:

Haemophilia, 2011, v. 17, n. 6, p. 957, doi. 10.1111/j.1365-2516.2011.02526.x

By:

DARGAUD, Y.;
PREVOST, C.;
LIENHART, A.;
CLAUDE BORDET, J.;
NEGRIER, C.

Publication type:

Article

Identifying non-responsive bleeding episodes in patients with haemophilia and inhibitors: a consensus definition.

Published in:

Haemophilia, 2011, v. 17, n. 1, p. e202, doi. 10.1111/j.1365-2516.2010.02377.x

By:

BERNTORP, E.;
COLLINS, P.;
D'OIRON, R.;
EWING, N.;
GRINGERI, A.;
NÉGRIER, C.;
YOUNG, G.

Publication type:

Article

New developments in laboratory diagnosis and monitoring.

Published in:

Haemophilia, 2010, v. 16, p. 61, doi. 10.1111/j.1365-2516.2010.02295.x

By:

KITCHEN, S.;
HAYWARD, C.;
NEGRIER, C.;
DARGAUD, Y.

Publication type:

Article

Thrombin generation in patients with factor XI deficiency and clinical bleeding risk.

Published in:

Haemophilia, 2010, v. 16, n. 5, p. 771, doi. 10.1111/j.1365-2516.2010.02246.x

By:

RUGERI, L.;
QUÉLIN, F.;
CHATARD, B.;
DE MAZANCOURT, P.;
NEGRIER, C.;
DARGAUD, Y.

Publication type:

Article

Optimizing on-demand treatment with NovoSeven® room temperature stable.

Published in:

Haemophilia, 2010, v. 16, p. 35, doi. 10.1111/j.1365-2516.2010.02258.x

By:

NEGRIER, C.

Publication type:

Article

Thrombin generation testing in haemophilia comprehensive care centres.

Published in:

Haemophilia, 2010, v. 16, n. 2, p. 223, doi. 10.1111/j.1365-2516.2009.02082.x

By:

DARGAUD, Y.;
NEGRIER, C.

Publication type:

Article

The application of bypassing-agent prophylaxis in haemophilia A patients with inhibitors: a meeting report.

Published in:

2009

By:

VALENTINO, L. A.;
CARCAO, M.;
MATHEW, P.;
LEISSINGER, C. A.;
BERNTORP, E.;
BLANCHETTE, V.;
ESCURIOLA-ETTINGSHAUSEN, C.;
EWENSTEIN, B.;
EWING, N.;
GRINGERI, A.;
HOOTS, W. K.;
NEGRIER, C.

Publication type:

Report

Contribution of genetical analysis for diagnosis of von Willebrand’s disease type 2B.

Published in:

2009

By:

Victor, M.;
Rugeri, L.;
Nougier, C.;
Meunier, S.;
Fretigny, M.;
Negrier, C.;
Vinciguerra, C.

Publication type:

Letter

European curriculum for thrombosis and haemostasis.

Published in:

Haemophilia, 2009, v. 15, n. 1, p. 337, doi. 10.1111/j.1365-2516.2008.01836.x

By:

ASTERMARK, J.;
NEGRIER, C.;
HERMANS, C.;
HOLME, P. A.;
KLAMROTH, R.;
KOTSI, P.;
DE MOERLOOSE, P.;
PASI, J.;
ROCINO, A.;
VON DEPKA, M.;
WINDYGA, J.;
LUDLAM, C. A.

Publication type:

Article

Haemophilic arthropathy from A to Z.

Published in:

Haemophilia, 2008, v. 14, p. 1, doi. 10.1111/j.1365-2516.2008.01731.x

By:

Négrier, C.;
Goudemand, J.;
Lambert, T.

Publication type:

Article

Factor VIII recovery after a single infusion of recalibrated ReFacto® in 14 severe haemophilia A patients.

Published in:

Haemophilia, 2007, v. 13, n. 4, p. 357, doi. 10.1111/j.1365-2516.2007.01482.x

By:

LAMBERT, T.;
GUÉROIS, C.;
GAY, V.;
STIELTJES, N.;
BERTRAND, M.-A.;
DERLON, A.;
SIGAUD, M.;
HASSOUN, A.;
NÉGRIER, C.;
COATMELEC, B.;
DREYFUS, M.;
DUBANCHET, A.

Publication type:

Article

Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conference.

Published in:

Haemophilia, 2006, v. 12, p. 1, doi. 10.1111/j.1365-2516.2006.01359.x

By:

BERNTORP, E.;
SHAPIRO, A.;
ASTERMARK, J.;
BLANCHETTE, V. S.;
COLLINS, P. W.;
DIMICHELE, D.;
ESCURIOLA, C.;
HAY, C. R. M.;
HOOTS, W. K.;
LEISSINGER, C. A.;
NEGRIER, C.;
OLDENBURG, J.;
PEERLINCK, K.;
REDING, M. T.;
HART, C.

Publication type:

Article

Basic aspects of bypassing agents.

Published in:

Haemophilia, 2006, v. 12, p. 48, doi. 10.1111/j.1365-2516.2006.01366.x

By:

NEGRIER, C.;
DARGAUD, Y.;
BORDET, J. C.

Publication type:

Article

Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conference.

Published in:

Haemophilia, 2006, v. 12, p. 1, doi. 10.1111/j.1365-2516.2006.01359.x

By:

BERNTORP, E.;
SHAPIRO, A.;
ASTERMARK, J.;
BLANCHETTE, V. S.;
COLLINS, P. W.;
DIMICHELE, D.;
ESCURIOLA, C.;
HAY, C. R. M.;
HOOTS, W. K.;
LEISSINGER, C. A.;
NEGRIER, C.;
OLDENBURG, J.;
PEERLINCK, K.;
REDING, M. T.;
HART, C.

Publication type:

Article

Basic aspects of bypassing agents.

Published in:

Haemophilia, 2006, v. 12, p. 48, doi. 10.1111/j.1365-2516.2006.01366.x

By:

NEGRIER, C.;
DARGAUD, Y.;
BORDET, J. C.

Publication type:

Article

Considerations in the management of patients with haemophilia and inhibitors.

Published in:

2006

By:

NÉGRIER, C.;
GOMPERTS, E. D.

Publication type:

Editorial

The history of FEIBA: a lifetime of success in the treatment of haemophilia complicated by an inhibitor.

Published in:

Haemophilia, 2006, v. 12, p. 4, doi. 10.1111/j.1365-2516.2006.01379.x

By:

NÉGRIER, C.;
GOMPERTS, E. D.;
OLDENBURG, J.

Publication type:

Article

FEIBA: looking toward the future.

Published in:

2006

By:

NÉGRIER, C.;
GOMPERTS, E. D.

Publication type:

Other

A retrospective postlicensure survey of FEIBA efficacy and safety.

Published in:

Haemophilia, 2006, v. 12, n. 4, p. 352, doi. 10.1111/j.1365-2516.2006.01284.x

By:

Dimichele, D.;
Négrier, C.

Publication type:

Article

The pharmacokinetics of coagulation factors.

Published in:

Haemophilia, 2006, v. 12, p. 1, doi. 10.1111/j.1365-2516.2006.01253.x

By:

Lee, M.;
Morfini, M.;
Negrier, C.;
Chamouard, V.

Publication type:

Article

Major surgery in a severe haemophilia A patient with high titre inhibitor: use of the thrombin generation test in the therapeutic decision.

Published in:

Haemophilia, 2005, v. 11, n. 5, p. 552, doi. 10.1111/j.1365-2516.2005.01141.x

By:

Dargaud, Y.;
Lienhart, A.;
Meunier, S.;
Hequet, O.;
Chavanne, H.;
Chamouard, V.;
Marin, S.;
Negrier, C.

Publication type:

Article

Consensus perspectives on surgery in haemophilia patients with inhibitors: summary statement.

Published in:

Haemophilia, 2004, v. 10, p. 50, doi. 10.1111/j.1365-2516.2004.00941.x

By:

Rodriguez-Merchan, E. C.;
Rocino, A.;
Ewenstein, B.;
Bartha, T. L.;
Batorova, A.;
Goudemand, J.;
Gringeri, A.;
Joao-Diniz, M.;
Lopaciuk, S.;
Negrier, C.;
Quintana, M.;
Tagariello, G.;
Tjonnfjord, G. E.;
Villar, V. A.;
Vorlova, Z.

Publication type:

Article

Continuous infusion of B-domain deleted recombinant factor VIII (ReFacto) in patients with haemophilia A undergoing surgery: clinical experience.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 452, doi. 10.1111/j.1365-2516.2004.01013.x

By:

Stieltjes, N.;
Altisent, C.;
Auerswald, G.;
Négrier, C.;
Pouzol, P.;
Reynaud, J.;
Roussel-Robert, V.;
Savidge, G. F.;
Villar, A.;
Schulman, S.

Publication type:

Article

Evaluation of the impact of information about treatment-related risks in patients receiving blood-derived or recombinant medications.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 572, doi. 10.1111/j.1365-2516.2004.00930.x

By:

Magli-Barioz, D.;
Ounnoughène, N.;
Paugy, P.;
Quarrè, M.-C.;
Vassilief, D.;
Lopez, I.;
Goudemand, J.;
Negrier, C.;
Assogba, U.;
Driss, F.;
A.-Dumont, M.;
Molho, P.

Publication type:

Article

Haemophilia and thrombophilia: an unexpected association!

Published in:

Haemophilia, 2004, v. 10, n. 4, p. 319, doi. 10.1111/j.1365-2516.2004.00906.x

By:

Dargaud, Y.;
Meunier, S.;
Negrier, C.

Publication type:

Article

Continuous intravenous infusion of a plasma-derived factor IX concentrate (Mononine® ) in haemophilia B.

Published in:

Haemophilia, 2003, v. 9, n. 2, p. 164, doi. 10.1046/j.1365-2516.2003.00721.x

By:

Hoots, W. K.;
Leissinger, C.;
Stabler, S.;
Schwartz, B. A.;
White, G.;
Dasani, H.;
Massion, C.;
Negrier, C.;
Schindel, F.;
Schulman, S.

Publication type:

Article

Unresolved issues in prophylaxis.

Published in:

Haemophilia, 2002, v. 8, n. 6, p. 817, doi. 10.1046/j.1365-2516.2002.00685.x

By:

Brown, S.A.;
Aledort, L.M.;
Astermark, J.;
Berntorp, E.;
van den Berg, M.;
Blanchette, V.;
Donfield, S.;
Gringeri, A.;
Hilgartner, M.;
Kulkarni, R.;
Leissinger, C.;
Negrier, C.;
Nuss, R.;
Petterson, H.;
Petrini, P.;
Poulios, N.;
Schramm, W.

Publication type:

Article